International Journal of Nephrology / 2017 / Article / Tab 2

Clinical Study

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 2

Baseline parameters of the patients.

DenosumabControl value

Corrected Ca (mg/dl)9.2 ± 0.59.0 ± 0.5NS
Phosphate (mg/dl)5.0 ± 1.34.8 ± 1.2NS
W-PTH (pg/ml)164 (58.5–228)157 (108–231)NS
ALP (U/l)276 ± 129270 ± 69NS

W-PTH: whole PTH. Median and interquartile range are shown for whole PTH. The reference range for ALP level is from 115 to 359 U/l.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.